Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron at Triage for Pediatric Gastroenteritis
NCT03052361Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jul 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastroenteritis comparing Ondansetron with Placebo (2 arms). Primary endpoint: Patient Disposition (Observation vs Discharge) at 12 hours. Started Jul 2017; status: terminated.
02
Drugs
ondansetron
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on NCT03052361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052361.